Hepatic expression levels of interferons and interferon-stimulated genes in patients with chronic hepatitis C

A phenotype-genotype correlation study

M. Noureddin, Y. Rotman, F. Zhang, H. Park, B. Rehermann, Emmanuel Thomas, T. J. Liang

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

IFNL4 is linked to hepatitis C virus treatment response and type III interferons (IFNs). We studied the functional associations among hepatic expressions of IFNs and IFN-stimulated genes (ISGs), and treatment response to peginterferon and ribavirin. Type I IFNs (IFNA1, IFNB1), type II (IFNG), type III (IFNL1, IFNL2/3), IFNL4 and ISG hepatic expressions were measured by qPCR from in 65 chronic hepatitis C (CHC) patients whose IFNL4-associated rs368234815 and IFNL3-associated rs12989760 genotype were determined. There was a robust correlation of hepatic expression within type I and type III IFNs and between type III IFNs and IFNL4 but no correlation between other IFN types. Expression of ISGs correlated with type III IFNs and IFNL4 but not with type I IFNs. Levels of ISGs and IFNL2/3 mRNAs were lower in IFNL3 rs12979860 CC patients compared with non-CC patients, and in treatment responders, compared with nonresponders. IFNL4-ΔG genotype was associated with high ISG levels and nonresponse. Hepatic levels of ISGs in CHC are associated with IFNL2/3 and IFNL4 expression, suggesting that IFNLs, not other types of IFNs, drive ISG expression. Hepatic IFNL2/3 expression is functionally linked to IFNL4 and IFNL3 polymorphisms, potentially explaining the tight association among ISG expression and treatment response.

Original languageEnglish (US)
Pages (from-to)321-329
Number of pages9
JournalGenes and Immunity
Volume16
Issue number5
DOIs
StatePublished - Jul 25 2015
Externally publishedYes

Fingerprint

Chronic Hepatitis C
Interferons
Genotype
Phenotype
Liver
Interferon Type I
Genes
Gene Expression
Ribavirin
Therapeutics
Hepacivirus
Messenger RNA

ASJC Scopus subject areas

  • Genetics(clinical)
  • Immunology
  • Genetics

Cite this

Hepatic expression levels of interferons and interferon-stimulated genes in patients with chronic hepatitis C : A phenotype-genotype correlation study. / Noureddin, M.; Rotman, Y.; Zhang, F.; Park, H.; Rehermann, B.; Thomas, Emmanuel; Liang, T. J.

In: Genes and Immunity, Vol. 16, No. 5, 25.07.2015, p. 321-329.

Research output: Contribution to journalArticle

Noureddin, M. ; Rotman, Y. ; Zhang, F. ; Park, H. ; Rehermann, B. ; Thomas, Emmanuel ; Liang, T. J. / Hepatic expression levels of interferons and interferon-stimulated genes in patients with chronic hepatitis C : A phenotype-genotype correlation study. In: Genes and Immunity. 2015 ; Vol. 16, No. 5. pp. 321-329.
@article{928893572f2e4152ad1f12840ae416e1,
title = "Hepatic expression levels of interferons and interferon-stimulated genes in patients with chronic hepatitis C: A phenotype-genotype correlation study",
abstract = "IFNL4 is linked to hepatitis C virus treatment response and type III interferons (IFNs). We studied the functional associations among hepatic expressions of IFNs and IFN-stimulated genes (ISGs), and treatment response to peginterferon and ribavirin. Type I IFNs (IFNA1, IFNB1), type II (IFNG), type III (IFNL1, IFNL2/3), IFNL4 and ISG hepatic expressions were measured by qPCR from in 65 chronic hepatitis C (CHC) patients whose IFNL4-associated rs368234815 and IFNL3-associated rs12989760 genotype were determined. There was a robust correlation of hepatic expression within type I and type III IFNs and between type III IFNs and IFNL4 but no correlation between other IFN types. Expression of ISGs correlated with type III IFNs and IFNL4 but not with type I IFNs. Levels of ISGs and IFNL2/3 mRNAs were lower in IFNL3 rs12979860 CC patients compared with non-CC patients, and in treatment responders, compared with nonresponders. IFNL4-ΔG genotype was associated with high ISG levels and nonresponse. Hepatic levels of ISGs in CHC are associated with IFNL2/3 and IFNL4 expression, suggesting that IFNLs, not other types of IFNs, drive ISG expression. Hepatic IFNL2/3 expression is functionally linked to IFNL4 and IFNL3 polymorphisms, potentially explaining the tight association among ISG expression and treatment response.",
author = "M. Noureddin and Y. Rotman and F. Zhang and H. Park and B. Rehermann and Emmanuel Thomas and Liang, {T. J.}",
year = "2015",
month = "7",
day = "25",
doi = "10.1038/gene.2015.11",
language = "English (US)",
volume = "16",
pages = "321--329",
journal = "Genes and Immunity",
issn = "1466-4879",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Hepatic expression levels of interferons and interferon-stimulated genes in patients with chronic hepatitis C

T2 - A phenotype-genotype correlation study

AU - Noureddin, M.

AU - Rotman, Y.

AU - Zhang, F.

AU - Park, H.

AU - Rehermann, B.

AU - Thomas, Emmanuel

AU - Liang, T. J.

PY - 2015/7/25

Y1 - 2015/7/25

N2 - IFNL4 is linked to hepatitis C virus treatment response and type III interferons (IFNs). We studied the functional associations among hepatic expressions of IFNs and IFN-stimulated genes (ISGs), and treatment response to peginterferon and ribavirin. Type I IFNs (IFNA1, IFNB1), type II (IFNG), type III (IFNL1, IFNL2/3), IFNL4 and ISG hepatic expressions were measured by qPCR from in 65 chronic hepatitis C (CHC) patients whose IFNL4-associated rs368234815 and IFNL3-associated rs12989760 genotype were determined. There was a robust correlation of hepatic expression within type I and type III IFNs and between type III IFNs and IFNL4 but no correlation between other IFN types. Expression of ISGs correlated with type III IFNs and IFNL4 but not with type I IFNs. Levels of ISGs and IFNL2/3 mRNAs were lower in IFNL3 rs12979860 CC patients compared with non-CC patients, and in treatment responders, compared with nonresponders. IFNL4-ΔG genotype was associated with high ISG levels and nonresponse. Hepatic levels of ISGs in CHC are associated with IFNL2/3 and IFNL4 expression, suggesting that IFNLs, not other types of IFNs, drive ISG expression. Hepatic IFNL2/3 expression is functionally linked to IFNL4 and IFNL3 polymorphisms, potentially explaining the tight association among ISG expression and treatment response.

AB - IFNL4 is linked to hepatitis C virus treatment response and type III interferons (IFNs). We studied the functional associations among hepatic expressions of IFNs and IFN-stimulated genes (ISGs), and treatment response to peginterferon and ribavirin. Type I IFNs (IFNA1, IFNB1), type II (IFNG), type III (IFNL1, IFNL2/3), IFNL4 and ISG hepatic expressions were measured by qPCR from in 65 chronic hepatitis C (CHC) patients whose IFNL4-associated rs368234815 and IFNL3-associated rs12989760 genotype were determined. There was a robust correlation of hepatic expression within type I and type III IFNs and between type III IFNs and IFNL4 but no correlation between other IFN types. Expression of ISGs correlated with type III IFNs and IFNL4 but not with type I IFNs. Levels of ISGs and IFNL2/3 mRNAs were lower in IFNL3 rs12979860 CC patients compared with non-CC patients, and in treatment responders, compared with nonresponders. IFNL4-ΔG genotype was associated with high ISG levels and nonresponse. Hepatic levels of ISGs in CHC are associated with IFNL2/3 and IFNL4 expression, suggesting that IFNLs, not other types of IFNs, drive ISG expression. Hepatic IFNL2/3 expression is functionally linked to IFNL4 and IFNL3 polymorphisms, potentially explaining the tight association among ISG expression and treatment response.

UR - http://www.scopus.com/inward/record.url?scp=84937816422&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937816422&partnerID=8YFLogxK

U2 - 10.1038/gene.2015.11

DO - 10.1038/gene.2015.11

M3 - Article

VL - 16

SP - 321

EP - 329

JO - Genes and Immunity

JF - Genes and Immunity

SN - 1466-4879

IS - 5

ER -